Phospho-CDK7 (Ser164) Antibody - #AF7315
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF7315, RRID:AB_2843755.
折りたたみ/展開
39 kDa protein kinase; CAK; CAK1; Cdk activating kinase; CDK-activating kinase 1; CDK-activating kinase; cdk7; CDK7_HUMAN; CDKN7; Cell division protein kinase 7; Cyclin dependent kinase 7; cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase); Cyclin-dependent kinase 7; HCAK; Homolog of Xenopus MO15 Cdk activating kinase; Kinase subunit of CAK; MO15; MO15, Xenopus, homolog of; P39 Mo15; p39MO15; Serine threonine kinase Stk1; Serine/threonine protein kinase 1; Serine/threonine protein kinase MO15; STK1; TFIIH basal transcription factor complex kinase subunit;
免疫原
- P50613 CDK7_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P50613 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
A2 | Acetylation | Uniprot | |
K6 | Ubiquitination | Uniprot | |
S7 | Phosphorylation | Uniprot | |
T25 | Phosphorylation | Uniprot | |
K32 | Ubiquitination | Uniprot | |
K41 | Ubiquitination | Uniprot | |
S106 | Phosphorylation | Uniprot | |
T110 | Phosphorylation | Uniprot | |
K139 | Ubiquitination | Uniprot | |
K160 | Ubiquitination | Uniprot | |
S161 | Phosphorylation | Q9HC98 (NEK6) | Uniprot |
S164 | Phosphorylation | P50613 (CDK7) , P24941 (CDK2) , P06493 (CDK1) | Uniprot |
Y169 | Phosphorylation | Uniprot | |
T170 | Phosphorylation | P50613 (CDK7) , P41743 (PRKCI) , P06493 (CDK1) , P24941 (CDK2) | Uniprot |
T175 | Phosphorylation | Uniprot | |
S217 | Phosphorylation | Uniprot | |
T287 | Phosphorylation | Uniprot | |
K291 | Ubiquitination | Uniprot | |
T316 | Phosphorylation | Uniprot | |
K318 | Ubiquitination | Uniprot | |
S321 | Phosphorylation | Uniprot | |
K328 | Ubiquitination | Uniprot | |
K330 | Ubiquitination | Uniprot | |
T332 | Phosphorylation | Uniprot |
PTMs - P50613 酵素として
Substrate | Site | Source |
---|---|---|
P03372 (ESR1) | S118 | Uniprot |
P04637 (TP53) | S33 | Uniprot |
P04637 (TP53) | S371 | Uniprot |
P04637 (TP53) | S376 | Uniprot |
P04637 (TP53) | S378 | Uniprot |
P04637 (TP53) | S392 | Uniprot |
P06493 (CDK1) | T161 | Uniprot |
P10275 (AR) | S516 | Uniprot |
P10276 (RARA) | S77 | Uniprot |
P11802 (CDK4) | T172 | Uniprot |
P13631 (RARG) | S77 | Uniprot |
P13631 (RARG) | S79 | Uniprot |
P14859 (POU2F1) | S385 | Uniprot |
P21127 (CDK11B) | T595 | Uniprot |
P24928 (POLR2A) | S1616 | Uniprot |
P24928 (POLR2A) | S1619 | Uniprot |
P24928 (POLR2A) | S1621 | Uniprot |
P24928 (POLR2A) | S1626 | Uniprot |
P24928 (POLR2A) | S1647 | Uniprot |
P24928 (POLR2A) | S1654 | Uniprot |
P24928 (POLR2A) | S1668 | Uniprot |
P24928 (POLR2A) | S1675 | Uniprot |
P24928 (POLR2A) | S1696 | Uniprot |
P24928 (POLR2A) | S1717 | Uniprot |
P24928 (POLR2A) | S1724 | Uniprot |
P24928 (POLR2A) | S1738 | Uniprot |
P24928 (POLR2A) | S1766 | Uniprot |
P24928 (POLR2A) | S1787 | Uniprot |
P24928 (POLR2A) | S1864 | Uniprot |
P24928 (POLR2A) | S1871 | Uniprot |
P24928 (POLR2A) | S1878 | Uniprot |
P24928 (POLR2A) | S1892 | Uniprot |
P24928 (POLR2A) | S1899 | Uniprot |
P24928 (POLR2A) | S1913 | Uniprot |
P24928 (POLR2A) | S1920 | Uniprot |
P24928 (POLR2A) | S1934 | Uniprot |
P24928 (POLR2A) | S1944 | Uniprot |
P24928 (POLR2A) | S1951 | Uniprot |
P24941 (CDK2) | S46 | Uniprot |
P24941 (CDK2) | T160 | Uniprot |
P24941 (CDK2) | T165 | Uniprot |
P24941 (CDK2) | Y168 | Uniprot |
P37231 (PPARG) | S112 | Uniprot |
P49736 (MCM2) | S4 | Uniprot |
P49736 (MCM2) | S5 | Uniprot |
P49736 (MCM2) | S7 | Uniprot |
P49736 (MCM2) | S13 | Uniprot |
P49736 (MCM2) | S27 | Uniprot |
P49736 (MCM2) | S40 | Uniprot |
P49736 (MCM2) | S41 | Uniprot |
P49736 (MCM2) | S53 | Uniprot |
P49736 (MCM2) | T59 | Uniprot |
P49736 (MCM2) | S108 | Uniprot |
P49736 (MCM2) | S139 | Uniprot |
P50613 (CDK7) | S164 | Uniprot |
P50613 (CDK7) | T170 | Uniprot |
Q00534 (CDK6) | T177 | Uniprot |
Q01094 (E2F1) | S403 | Uniprot |
Q01094 (E2F1) | T433 | Uniprot |
Q13285 (NR5A1) | S203 | Uniprot |
Q14847-1 (LASP1) | S146 | Uniprot |
Q15797 (SMAD1) | S206 | Uniprot |
Q9BYE7-1 (PCGF6) | S30 | Uniprot |
Q9H0D6 (XRN2) | T439 | Uniprot |
Q9NYV4 (CDK12) | T893 | Uniprot |
Q9UPZ9 (ICK) | T157 | Uniprot |
研究背景
Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C-terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.
Phosphorylation of Ser-164 during mitosis inactivates the enzyme. Phosphorylation of Thr-170 is required for activity. Phosphorylated at Ser-164 and Thr-170 by CDK2.
Nucleus. Cytoplasm. Cytoplasm>Perinuclear region.
Note: Colocalizes with PRKCI in the cytoplasm and nucleus. Translocates from the nucleus to cytoplasm and perinuclear region in response to DNA-bound peptides.
Ubiquitous.
Associates primarily with cyclin-H (CCNH) and MAT1 to form the CAK complex. CAK can further associate with the core-TFIIH to form the TFIIH basal transcription factor; this complex is sensitive to UV light. The CAK complex binds to p53/TP53 in response to DNA damage. Interacts with CDK2, SF1/NR5A1, PUF60 and PRKCI.
Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.
研究領域
· Cellular Processes > Cell growth and death > Cell cycle. (View pathway)
· Genetic Information Processing > Transcription > Basal transcription factors.
· Genetic Information Processing > Replication and repair > Nucleotide excision repair.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.